111 related articles for article (PubMed ID: 38101610)
1. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.
Dai X; Chen W; Qiao Y; Chen X; Chen Y; Zhang K; Zhang Q; Duan X; Li X; Zhao J; Tian F; Liu K; Dong Z; Lu J
Cancer Lett; 2024 Feb; 582():216596. PubMed ID: 38101610
[TBL] [Abstract][Full Text] [Related]
2. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression.
Zhi H; Lian J
Cell Biochem Funct; 2019 Jul; 37(5):340-347. PubMed ID: 31062382
[TBL] [Abstract][Full Text] [Related]
3. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
[TBL] [Abstract][Full Text] [Related]
4. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
5. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac
Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y
J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719
[TBL] [Abstract][Full Text] [Related]
6. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
Mao D; Zhang X; Wang Z; Xu G; Zhang Y
Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
[TBL] [Abstract][Full Text] [Related]
7. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
9. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
10. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
[TBL] [Abstract][Full Text] [Related]
11. Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
Wang G; Feng CC; Chu SJ; Zhang R; Lu YM; Zhu JS; Zhang J
Int J Oncol; 2015 Nov; 47(5):1767-74. PubMed ID: 26398368
[TBL] [Abstract][Full Text] [Related]
12. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lncTCF7 inhibits cell migration and invasion in colorectal cancer via inhibiting TCF7 expression.
Wu B; Chen M; Gao M; Cong Y; Jiang L; Wei J; Huang J
Hum Cell; 2019 Jan; 32(1):31-40. PubMed ID: 30225781
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.
Liao K; Li J; Wang Z
Int J Clin Exp Pathol; 2014; 7(12):8684-91. PubMed ID: 25674233
[TBL] [Abstract][Full Text] [Related]
15. γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules.
Prasad S; Gupta SC; Tyagi AK; Aggarwal BB
Br J Cancer; 2016 Sep; 115(7):814-24. PubMed ID: 27575851
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer.
Bai B; Wu F; Ying K; Xu Y; Shan L; Lv Y; Gao X; Xu D; Lu J; Xie B
Theranostics; 2021; 11(13):6225-6239. PubMed ID: 33995655
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.
Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K
Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439
[TBL] [Abstract][Full Text] [Related]
19. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
Liu K; Li J; Wu X; Chen M; Luo F; Li J
Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
